HAG
DXCM icon

HighPoint Advisor Group’s DexCom DXCM Stock Holding History

HighPoint Advisor Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,479
Closed -$391K – 696
2025
Q2 		$391K Buy
4,479
+283
+7% +$22.2K 0.02% 441
2025
Q1 		$299K Sell
4,196
-749
-15% -$61.1K 0.02% 491
2024
Q4 		$427K Buy
+4,945
New +$366K 0.02% 414
2024
Q3 		– Sell
-3,448
Closed -$240K – 711
2024
Q2 		$240K Sell
3,448
-173
-5% -$21.9K 0.01% 540
2024
Q1 		$452K Buy
3,621
+15
+0.4% +$1.89K 0.03% 367
2023
Q4 		$505K Buy
+3,606
New +$368K 0.04% 353
2022
Q2 		$263K Buy
+3,480
New +$318K 0.03% 420
2021
Q3 		$406K Buy
2,968
+188
+7% +$23.7K 0.04% 346
2021
Q2 		$297K Buy
2,780
+516
+23% +$49.6K 0.03% 398
2021
Q1 		$217K Hold
2,264
– – 0.03% 440
2020
Q4 		$227K Sell
2,264
-6,128
-73% -$547K 0.03% 405
2020
Q3 		$745K Buy
8,392
+596
+8% +$62.3K 0.13% 131
2020
Q2 		$780K Sell
7,796
-316
-4% -$28.3K 0.17% 113
2020
Q1 		$674K Buy
+8,112
New +$505K 0.16% 110

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HighPoint Advisor Group's DXCM Position: Q3 2025 in Review

HighPoint Advisor Group sold out of DexCom (DXCM) in Q3 2025, closing a stake of 4,479 shares — an estimated $391K sold.

HighPoint Advisor Group first reported a position in DXCM in Q1 2020 and held it in 14 quarters. The position peaked at $780K in Q2 2020. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • HighPoint Advisor Group reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • HighPoint Advisor Group sold 4,479 DexCom shares in Q3 2025, an estimated $391K.
  • HighPoint Advisor Group first reported a position in DexCom in Q1 2020 and held it in 14 quarters.
  • HighPoint Advisor Group's DexCom position peaked at $780K in Q2 2020.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on HighPoint Advisor Group's 13F filing for Q3 2025, filed 5 Nov 2025.